Phio pharmaceuticals fintel
Webb30 mars 2024 · Phio Pharmaceuticals - PHIO News Today $5.99 +0.16 (+2.74%) (As of 03/30/2024 10:41 AM ET) Compare Today's Range $5.75 $5.99 50-Day Range $0.51 $6.85 52-Week Range $3.90 $29.04 Volume 1,039 shs Average Volume 36,447 shs Market Capitalization $6.89 million P/E Ratio N/A Dividend Yield N/A Price Target N/A Profile … WebbPhio Pharmaceuticals Contact Us Contact Us Get in touch with us. General inquiries: [email protected] Investor relations information: [email protected] …
Phio pharmaceuticals fintel
Did you know?
Webb6 apr. 2024 · Phio Pharmaceuticals (NASDAQ:PHIO) has a recorded net income of -$11.48 million. PHIO has generated -$10.68 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts … WebbPhio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAi technology makes immune cells more effective in …
Webb13 apr. 2024 · Phio Pharmaceuticals Corporation Aktie ISIN: US71880W4024 · WKN: A3D451 · SYM: PHIO 5,710 USD -1,21 % -0,070 USD Letzter Kurs 06.04.23 · NYSE 5,440 USD 100 STK Geldkurs 06.04.23 6,000 USD 100... WebbResumen PHIO Gráfico técnico Phio Pharmaceuticals Corp 5,527 + 0,259 ( + 4,92 %) S 1 semana 1 año Máx. Último cierre 5,268 Rango día 5,321 - 6 Ingresos - Apertura 5,321 52 semanas 3,9 - 29,04...
Webb12 apr. 2024 · Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics. The company was founded on … Webb22 feb. 2024 · Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAi technology is designed to make immune cells more effective in killing tumor cells. Corporate Presentation The following is an investor update, effective January 2024, presented by Robert Bitterman. Mr.
WebbDeutsche Bank Ag\ closes position in PHIO / Phio Pharmaceuticals Corp Institutional Ownership: 13F and NPORT Filings The Security and Class in the table below are shown …
WebbPHIO / Phio Pharmaceuticals Corp Implied Volatility - Fintel Labs. Fintel ... how many sides does a rubik\u0027s cube haveWebbPHIO Short Sale Transactions - Phio Pharmaceuticals Corp EXTENDED. Day's Range - 52 Week Range - how did mass media create national cultureWebb22 feb. 2024 · Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical-stage biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYL™)... how did mass incarceration beginWebb1 mars 2024 · Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYL™) therapeutic... how many sides does a rhombus have 4WebbPHIO / Phio Pharmaceuticals Corp - Net Long/Short Value This page provides the net long/short valuations for each institutional holding reported via 13F or NPORT filings. To … how did massachusetts get its nameWebbPhio Pharmaceuticals Reports 2024 Year End Financial Results and Provides Business Update. Additional Formats PDF Version. February 22, 2024 Phio Pharmaceuticals Appoints Robert Bitterman as President and Chief Executive Officer. Additional Formats PDF Version. February 13, 2024 ... how many sides does a rhombusWebb2024-11-14 - BlackRock Inc. has filed a 13F-HR form disclosing ownership of 19 shares of Phio Pharmaceuticals Corp (US:PHIO) with total holdings valued at $0 USD as of 2024 … how many sides does a right angled triangle